Literature DB >> 23319802

mTOR complex 2 is involved in regulation of Cbl-dependent c-FLIP degradation and sensitivity of TRAIL-induced apoptosis.

Liqun Zhao1, Ping Yue, Fadlo R Khuri, Shi-Yong Sun.   

Abstract

The mTOR positively regulates cell proliferation and survival through forming 2 complexes with raptor (mTOR complex 1; mTORC1) or rictor (mTOR complex 2; mTORC2). Compared with the mTORC1, relatively little is known about the biologic functions of mTORC2. This study focuses on addressing whether mTORC2 regulates apoptosis, particularly induced by TRAIL (TNFSF10). Using the mTOR kinase inhibitor, PP242, as a research tool, we found that it synergized with TRAIL to augment apoptosis of cancer cells. PP242 reduced the abundance of the short form of c-FLIP (FLIP(S), CFLAR(S)) and survivin (BIRC5). Enforced expression of ectopic FLIP(S), but not survivin, attenuated augmented apoptosis induced by PP242 plus TRAIL. Thus, it is FLIP(S) downregulation that contributes to synergistic induction of apoptosis by PP242 plus TRAIL. PP242 decreased FLIP(S) stability, increased FLIP(S) ubiquitination, and facilitated FLIP(S) degradation. Moreover, knockdown of the E3 ligase Cbl (CBL) abolished PP242-induced FLIP(S) reduction. Thus, PP242 induces Cbl-dependent degradation of FLIP(S), leading to FLIP(S) downregulation. Consistently, knockdown of rictor or mTOR, but not raptor, mimicked PP242 in decreasing FLIP(S) levels and sensitizing cells to TRAIL. Rictor knockdown decreased FLIP(S) stability, whereas enforced expression of rictor stabilized FLIP(S). Moreover, silencing of Cbl abrogated FLIP(S) reduction induced by rictor knockdown. Collectively we conclude that it is mTORC2 inhibition that results in FLIP(S) downregulation and subsequent sensitization of TRAIL-induced apoptosis. Our findings provide the first evidence showing that mTORC2 stabilizes FLIP(S), hence connecting mTORC2 signaling to the regulation of death receptor-mediated apoptosis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23319802      PMCID: PMC3602308          DOI: 10.1158/0008-5472.CAN-12-3710

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  51 in total

Review 1.  Lessons from TRAIL-resistance mechanisms in colorectal cancer cells: paving the road to patient-tailored therapy.

Authors:  Caroline M M Van Geelen; Elisabeth G E de Vries; Steven de Jong
Journal:  Drug Resist Updat       Date:  2005-01-08       Impact factor: 18.500

2.  Celecoxib promotes c-FLIP degradation through Akt-independent inhibition of GSK3.

Authors:  Shuzhen Chen; Wei Cao; Ping Yue; Chunhai Hao; Fadlo R Khuri; Shi-Yong Sun
Journal:  Cancer Res       Date:  2011-08-25       Impact factor: 12.701

3.  Rapid turnover of c-FLIPshort is determined by its unique C-terminal tail.

Authors:  Minna Poukkula; Aura Kaunisto; Ville Hietakangas; Konstantin Denessiouk; Tuire Katajamäki; Mark S Johnson; Lea Sistonen; John E Eriksson
Journal:  J Biol Chem       Date:  2005-05-10       Impact factor: 5.157

4.  mTOR controls FLIPS translation and TRAIL sensitivity in glioblastoma multiforme cells.

Authors:  Amith Panner; C David James; Mitchel S Berger; Russell O Pieper
Journal:  Mol Cell Biol       Date:  2005-10       Impact factor: 4.272

5.  Differential effects of synthetic nuclear retinoid receptor-selective retinoids on the growth of human non-small cell lung carcinoma cells.

Authors:  S Y Sun; P Yue; M I Dawson; B Shroot; S Michel; W W Lamph; R A Heyman; M Teng; R A Chandraratna; K Shudo; W K Hong; R Lotan
Journal:  Cancer Res       Date:  1997-11-01       Impact factor: 12.701

6.  Death receptor regulation and celecoxib-induced apoptosis in human lung cancer cells.

Authors:  Xiangguo Liu; Ping Yue; Zhongmei Zhou; Fadlo R Khuri; Shi-Yong Sun
Journal:  J Natl Cancer Inst       Date:  2004-12-01       Impact factor: 13.506

7.  Upregulation of FLIP(S) by Akt, a possible inhibition mechanism of TRAIL-induced apoptosis in human gastric cancers.

Authors:  Seon Young Nam; Gyung-Ah Jung; Gwong-Cheung Hur; Hee-Yong Chung; Woo Ho Kim; Dai-Wu Seol; Byung Lan Lee
Journal:  Cancer Sci       Date:  2003-12       Impact factor: 6.716

8.  Downregulation of Bcl-2, FLIP or IAPs (XIAP and survivin) by siRNAs sensitizes resistant melanoma cells to Apo2L/TRAIL-induced apoptosis.

Authors:  M Chawla-Sarkar; S I Bae; F J Reu; B S Jacobs; D J Lindner; E C Borden
Journal:  Cell Death Differ       Date:  2004-08       Impact factor: 15.828

9.  Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive.

Authors:  Estela Jacinto; Robbie Loewith; Anja Schmidt; Shuo Lin; Markus A Rüegg; Alan Hall; Michael N Hall
Journal:  Nat Cell Biol       Date:  2004-10-03       Impact factor: 28.824

10.  The E3 ubiquitin ligase itch couples JNK activation to TNFalpha-induced cell death by inducing c-FLIP(L) turnover.

Authors:  Lufen Chang; Hideaki Kamata; Giovanni Solinas; Jun-Li Luo; Shin Maeda; K Venuprasad; Yun-Cai Liu; Michael Karin
Journal:  Cell       Date:  2006-02-10       Impact factor: 41.582

View more
  19 in total

1.  Feature Article: mTOR complex 2-Akt signaling at mitochondria-associated endoplasmic reticulum membranes (MAM) regulates mitochondrial physiology.

Authors:  Charles Betz; Daniele Stracka; Cristina Prescianotto-Baschong; Maud Frieden; Nicolas Demaurex; Michael N Hall
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-12       Impact factor: 11.205

2.  mTOR Complex 2 Stabilizes Mcl-1 Protein by Suppressing Its Glycogen Synthase Kinase 3-Dependent and SCF-FBXW7-Mediated Degradation.

Authors:  Junghui Koo; Ping Yue; Xingming Deng; Fadlo R Khuri; Shi-Yong Sun
Journal:  Mol Cell Biol       Date:  2015-04-27       Impact factor: 4.272

Review 3.  FLIP the Switch: Regulation of Apoptosis and Necroptosis by cFLIP.

Authors:  Yuichi Tsuchiya; Osamu Nakabayashi; Hiroyasu Nakano
Journal:  Int J Mol Sci       Date:  2015-12-18       Impact factor: 5.923

4.  Evodiamine induces apoptosis and enhances TRAIL-induced apoptosis in human bladder cancer cells through mTOR/S6K1-mediated downregulation of Mcl-1.

Authors:  Tao Zhang; Shanna Qu; Qi Shi; Dalin He; Xunbo Jin
Journal:  Int J Mol Sci       Date:  2014-02-21       Impact factor: 5.923

5.  Roles of c-FLIP in Apoptosis, Necroptosis, and Autophagy.

Authors:  Ahmad R Safa
Journal:  J Carcinog Mutagen       Date:  2013

6.  c-FLIP links mTORC2 to apoptosis.

Authors:  Liqun Zhao; Shi-Yong Sun
Journal:  Oncoscience       Date:  2014-05-20

7.  Galangin sensitizes TRAIL-induced apoptosis through down-regulation of anti-apoptotic proteins in renal carcinoma Caki cells.

Authors:  Min Ae Han; Dong Hee Lee; Seon Min Woo; Bo Ram Seo; Kyoung-Jin Min; Shin Kim; Jong-Wook Park; Sang Hyun Kim; Yung Hyun Choi; Taeg Kyu Kwon
Journal:  Sci Rep       Date:  2016-01-04       Impact factor: 4.379

8.  Inhibition of mTOR complex 2 induces GSK3/FBXW7-dependent degradation of sterol regulatory element-binding protein 1 (SREBP1) and suppresses lipogenesis in cancer cells.

Authors:  S Li; Y-T Oh; P Yue; F R Khuri; S-Y Sun
Journal:  Oncogene       Date:  2015-04-20       Impact factor: 9.867

9.  Intrinsic cellular signaling mechanisms determine the sensitivity of cancer cells to virus-induced apoptosis.

Authors:  Yunfei Wang; Dawei Li; Jian Luo; Guimei Tian; Lisa Y Zhao; Daiqing Liao
Journal:  Sci Rep       Date:  2016-11-16       Impact factor: 4.379

10.  Maintaining glycogen synthase kinase-3 activity is critical for mTOR kinase inhibitors to inhibit cancer cell growth.

Authors:  Junghui Koo; Ping Yue; Anthony A Gal; Fadlo R Khuri; Shi-Yong Sun
Journal:  Cancer Res       Date:  2014-03-13       Impact factor: 13.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.